Meditope Biosciences

Meditope Biosciences

Biotechnology, 177 E BLVD Ste 200, Pasadena, California, Colorado, 91105, United States, 1-10 Employees

meditope.com

  • facebook
  • LinkedIn

phone no Phone Number: 62********

Who is MEDITOPE BIOSCIENCES

Meditope Biosciences, Inc. is in possession of a revolutionary antibody platform technology called SnAP (Site-specific, novel, Antibody Platform), which can turn antibodies into a LEGO-li...

Read More

map
  • 177 E Colorado BLVD Ste 200, Pasadena, California, 91105, United States Headquarters: 177 E Colorado BLVD Ste 200, Pasadena, California, 91105, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from MEDITOPE BIOSCIENCES

Meditope Biosciences Org Chart and Mapping

Employees

Bob McKenzie

Executive Vice President Business Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Meditope Biosciences

Answer: Meditope Biosciences's headquarters are located at 177 E BLVD Ste 200, Pasadena, California, Colorado, 91105, United States

Answer: Meditope Biosciences's phone number is 62********

Answer: Meditope Biosciences's official website is https://meditope.com

Answer: Meditope Biosciences's revenue is Under $1 Million

Answer: Meditope Biosciences's SIC: 8731

Answer: Meditope Biosciences has 1-10 employees

Answer: Meditope Biosciences is in Biotechnology

Answer: Meditope Biosciences contact info: Phone number: 62******** Website: https://meditope.com

Answer: Meditope Biosciences, Inc. is in possession of a revolutionary antibody platform technology called SnAP (Site-specific, novel, Antibody Platform), which can turn antibodies into a LEGO-like system. The power, elegance, and simplicity of SnAP allows for a broad range of molecules toxins, proteins, radiolabels, other antibodies to be snapped on or off an antibody with predictability, precision and control. Meditope is using this technology to develop a preclinical pipeline of compelling cancer drugs including two new immuno-oncology product for prostate and bladder cancers.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access